Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Identification of a new peptide targeting the HR1 spike domain as a pan-coronavirus fusion inhibitor

May 25, 2020

Post-translational antibody modification triggers allergies

May 22, 2020

CanSino initiates phase I trial of PCV13i vaccine

May 21, 2020

The world according to GARP

May 21, 2020

Adjuvance receives NIAID funding to evaluate vaccine adjuvant with SARS-CoV2 antigen

May 20, 2020

New oral multivalent vaccine candidate protects mice against H. pylori infection

May 20, 2020

Bristol-Myers Squibb presents new Toll-like receptor antagonists

May 19, 2020

Designer proteins for RSV vaccine

May 18, 2020

T-cell mutations contribute to GvHD

May 12, 2020

CanSino initiates phase I study of three-component DTcP vaccine candidate

May 11, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...